Alternating Electric Field Therapy to Disrupt Cancer for

Project: Research project

Description

Alternating Electric Field Therapy to Disrupt Cancer for Immunotherapy
StatusActive
Effective start/end date1/8/1812/31/19

Funding

  • Boston Scientific Corporation

Fingerprint

Immunotherapy
Neoplasms
Therapeutics